Home > Financial Ratios > BIOCON

BIOCON
EBIT Growth

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) -48.3411.3889.9225.26-6.64

What is the latest EBIT Growth ratio of BIOCON ?

The latest EBIT Growth ratio of BIOCON is -48.34 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026-48.34
Mar202511.38
Mar202489.92
Mar202325.26
Mar2022-6.64

How is EBIT Growth of BIOCON Trending?

Years EBIT Growth % Change
Mar2026 -48.34
Negative
Mar2025 11.38
-87.34
Mar2024 89.92
255.98
Mar2023 25.26
Positive
Mar2022 -6.64 -

Other Financial Ratios of BIOCON


Compare EBIT Growth ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹53,739.4 Cr -6.2% -16.5% -6.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,831.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,074.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,355.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹107,439.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,417.0 Cr 1.5% 3.1% 0.4% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-6.2%

-16.5%

-6.4%

SENSEX

0.6%

-1.4%

-10.7%


You may also like the below Video Courses